Moonlake Immunotherapeutics (MLTX)

Date: O: H: L: C: Vol:

Finanzdaten der Moonlake Immunotherapeutics-Aktie (MLTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	11.94%61.66	70.02	65.22	71.43	60.70
Research and Development	7.88%50.22	54.52	56.01	60.64	49.76
Operating Income/Loss	11.94%-61.66	-70.02	-65.22	-71.43	-60.70
Income Tax Expense/Benefit	85.53%0.09	0.62	0.25	0.12	0.10
	11.34%-61.81	-69.71	-63.02	-70.69	-56.05
Attributable To Parent	11.34%-61.81	-69.71	-62.43	-69.73	-55.22
Attributable To Noncontrolling Interest	-	-	-0.59	-0.97	-0.83
Basic Average Shares	3.71%73.92	71.27	1.17	63.37	63.28
Diluted Average Shares	3.71%73.92	71.27	1.17	63.37	63.28
Basic Earnings Per Share	14.29%-0.84	-0.98	-0.92	-1.10	-0.87
Diluted Earnings Per Share	14.29%-0.84	-0.98	-0.92	-1.10	-0.87